Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2013 1
2016 3
2017 4
2018 6
2019 4
2020 3
2021 2
2022 1
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system.
Tang J, Lam GT, Brooks RD, Miles M, Useckaite Z, Johnson IR, Ung BS, Martini C, Karageorgos L, Hickey SM, Selemidis S, Hopkins AM, Rowland A, Vather R, O'Leary JJ, Brooks DA, Caruso MC, Logan JM. Tang J, et al. Among authors: brooks da. Cancer Lett. 2024 Mar 31;585:216639. doi: 10.1016/j.canlet.2024.216639. Epub 2024 Jan 28. Cancer Lett. 2024. PMID: 38290660 Free article. Review.
Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapy.
Kelly TE, Spillane CL, Ward MP, Hokamp K, Huang Y, Tewari P, Martin CM, Norris LA, Mohamed BM, Bates M, Brooks R, Selemidis S, Brooks DA, Kamran W, Saadeh FA, O'Toole SA, O'Leary JJ. Kelly TE, et al. Among authors: brooks da. Front Cell Dev Biol. 2023 Dec 7;11:1150991. doi: 10.3389/fcell.2023.1150991. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38143926 Free PMC article.
Publisher Correction to: Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer.
Martini C, Logan JM, Sorvina A, Prabhakaran S, Ung BS, Johnson IRD, Hickey SM, Brooks RD; kConFab Consortium; Caruso MC, Klebe S, Karageorgos L, O'Leary JJ, Delahunt B, Samaratunga H, Brooks DA. Martini C, et al. Among authors: brooks da. Virchows Arch. 2023 Sep 29. doi: 10.1007/s00428-023-03666-8. Online ahead of print. Virchows Arch. 2023. PMID: 37773453 No abstract available.
Insights into Melanoma Clinical Practice: A Perspective for Future Research.
Lam GT, Martini C, Brooks T, Prabhakaran S, Hopkins AM, Ung BS, Tang J, Caruso MC, Brooks RD, Johnson IRD, Sorvina A, Hickey SM, Karageorgos L, Klebe S, O'Leary JJ, Brooks DA, Logan JM. Lam GT, et al. Among authors: brooks da. Cancers (Basel). 2023 Sep 19;15(18):4631. doi: 10.3390/cancers15184631. Cancers (Basel). 2023. PMID: 37760601 Free PMC article.
Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer.
Martini C, Logan JM, Sorvina A, Prabhakaran S, Ung BSY, Johnson IRD, Hickey SM, Brooks RD; kConFab Consortium; Caruso MC, Klebe S, Karageorgos L, O'Leary JJ, Delahunt B, Samaratunga H, Brooks DA. Martini C, et al. Among authors: brooks da. Virchows Arch. 2023 Sep 14. doi: 10.1007/s00428-023-03643-1. Online ahead of print. Virchows Arch. 2023. PMID: 37704825
Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression.
Lazniewska J, Li KL, Johnson IRD, Sorvina A, Logan JM, Martini C, Moore C, Ung BS, Karageorgos L, Hickey SM, Prabhakaran S, Heatlie JK, Brooks RD, Huzzell C, Warnock NI, Ward MP, Mohammed B, Tewari P, Martin C, O'Toole S, Edgerton LB, Bates M, Moretti P, Pitson SM, Selemidis S, Butler LM, O'Leary JJ, Brooks DA. Lazniewska J, et al. Among authors: brooks da. Sci Rep. 2023 Aug 18;13(1):13489. doi: 10.1038/s41598-023-40347-7. Sci Rep. 2023. PMID: 37596305 Free PMC article.
Altered endosomal-lysosomal biogenesis in melanoma.
Lam GT, Sorvina A, Martini C, Prabhakaran S, Ung BS, Lazniewska J, Moore CR, Beck AR, Hopkins AM, Johnson IRD, Caruso MC, Hickey SM, Brooks RD, Jackett L, Karageorgos L, Foster-Smith EJ, Malone V, Klebe S, O'Leary JJ, Brooks DA, Logan JM. Lam GT, et al. Among authors: brooks da. Neoplasia. 2023 Sep;43:100924. doi: 10.1016/j.neo.2023.100924. Epub 2023 Aug 9. Neoplasia. 2023. PMID: 37562257 Free PMC article.
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1.
Logan JM, Hopkins AM, Martini C, Sorvina A, Tewari P, Prabhakaran S, Huzzell C, Johnson IRD, Hickey SM, Ung BS, Lazniewska J, Brooks RD, Moore CR, Caruso MC, Karageorgos L, Martin CM, O'Toole S, Bogue Edgerton L, Ward MP, Bates M, Selemidis S, Esterman A, Heffernan S, Keegan H, Ní Mhaolcatha S, O'Connor R, Malone V, Carter M, Ryan K, Clarke A, Brady N, Klebe S, Samaratunga H, Delahunt B, Sorich MJ, Moretti K, Butler LM, O'Leary JJ, Brooks DA. Logan JM, et al. Among authors: brooks da. Cancers (Basel). 2023 Jun 16;15(12):3215. doi: 10.3390/cancers15123215. Cancers (Basel). 2023. PMID: 37370825 Free PMC article.
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer.
Martini C, Logan JM, Sorvina A, Gordon C, Beck AR, S-Y Ung B, Caruso MC, Moore C, Hocking A, Johnson IRD, Li KL, Karageorgos L, Hopkins AM, Esterman AJ, Huzzell C, Brooks RD, Lazniewska J, Hickey SM, Bader C, Parkinson-Lawrence E, Weigert R, Sorich MJ, Tewari P, Martin C, O'Toole S, Bates M, Ward M, Mohammed B, Keegan H, Watson W, Prendergast S, Heffernan S, NiMhaolcatha S, O'Connor R, Malone V, Carter M, Ryan K, Brady N, Clarke A, Sokol F, Prabhakaran S, Stahl J, Klebe S, Samaratunga H, Delahunt B, Selemidis S, Moretti KL, Butler LM, O'Leary JJ, Brooks DA. Martini C, et al. Among authors: brooks da. Pathology. 2023 Feb;55(1):40-51. doi: 10.1016/j.pathol.2022.08.001. Epub 2022 Aug 20. Pathology. 2023. PMID: 36089417 Free article.
31 results